Oasis Diagnostics™ Corporation
Oasis Diagnostics™ Corporation was founded to conceive, develop and commercialize high-quality tools for the non-invasive diagnosis and detection of diseases based on less-invasive specimens, particularly oral fluid (or saliva) and whole blood. The Company's products, either directly or through established partnerships, address areas including drugs of abuse, infectious diseases (including HIV and tuberculosis), anthrax immunity, steroid hormones, oncology markers and others.
Early diagnosis is the key to disease prevention efforts on a global basis and Oasis Diagnostics™ directs its research efforts to developing rapid and laboratory based diagnostic products, which fit into a Corporate objective of improving the quality of healthcare for our global customers.
With particular emphasis on saliva based diagnostics and salivary applications, Oasis Diagnostics™ Corporation is always open to discussing new business opportunities with potential collaborative partners, which fit into our Corporate strategy.
Oasis Diagnostics™ Corporation is a global company targeting both domestic and international markets for its innovative saliva diagnostic portfolio. Our products can be found listed to your left.